At present, oseltamivir is an effective drug for preventing and treating influenza virus, and its patent right will expire on 20 16. With the spread of bird flu around the world, this drug has also become a hot drug. Recently, it was reported that the oseltamivir phosphate capsules of Yichang Changjiang Pharmaceutical Co., Ltd. have been identified as anti-influenza reserve drugs in Guangdong Province, which indicates that the localization of raw materials and capsules in oseltamivir phosphate has achieved the final results and laid a solid foundation for preventing and controlling the outbreak and epidemic of human influenza in China.
The full name should be oseltamivir phosphate capsules, a box around 200 yuan.